Joe Biden Donald Trump Split File
CNN  — 

The Trump-aligned America First Action super PAC is spending $10 million targeting Joe Biden in Pennsylvania, Michigan and Wisconsin.

It will be spent on digital, cable, and mail and is “the group’s first wave of independent expenditure spending in the 2020 election cycle,” according to a news release.

The ad buy represents the super PAC’s first foray into the 2020 race and will run through May.

The anti-Biden blitz will be the rebuttal many Trump allies think the campaign or pro-Trump outside groups should have launched weeks ago to shield President Donald Trump from the beating he is taking on the airwaves as a result of pro-Biden groups’ investment in anti-Trump ads during the coronavirus pandemic.

The New York Times first reported the America First Action ad buy.

The ads come as left-leaning super PAC Priorities USA Action Fund is currently airing an attack ad hitting the President’s coronavirus response, repeating Trump’s own words as the virus progressed alongside the rising cases.

The Trump campaign last week sent a cease-and-desist letter to television stations running the ad in key swing states of Florida, Michigan, Wisconsin and Pennsylvania, because it “contains the false assertion that President Trump called the coronavirus a ‘hoax,’ when in fact he was referring to Democrat criticisms and politicization of the federal response to the public health crisis.”

In response, Priorities USA continued to air the ad and expanded it to Arizona. It also launched the ad digitally in Spanish.

The pro-Democratic group announced Wednesday it would expand its original pro-Biden ad blitz by $1 million across the same three states, extending its run time by a week, as well as purchase more digital ads in those states and Florida. The group framed it as a direct response to America First Action’s move this week.

The competing ads include one hammering Trump over his early handling of the coronavirus outbreak, during which the President downplayed the risk to Americans from Covid-19.